Texas Instruments Incorporated

(NASDAQ Global Select)
Bullish +75

TXN vs. LRCX: Which Semiconductor Stock Is the Better Buy Right Now?

πŸ“ˆ Texas Instruments Q1 2026 revenues increased 19% year-over-year to $4.83 billion with EPS rising 31% to $1.68.

πŸš€ TXN data center business annual run rate reached ~$1.2 billion in 2025, growing over 50% year-over-year.

βš™οΈ Lam Research raised its 2026 wafer fabrication equipment spending outlook to $140 billion from $135 billion.

πŸ“Š LRCX Q3 fiscal 2026 revenues rose 23.8% to $5.84 billion, beating consensus estimates by 1.3%.

πŸ’° TXN non-GAAP gross margin expanded 120 bps to 58% in Q1 2026 driven by manufacturing scale.

πŸ”¬ LRCX advanced packaging revenues expected to grow more than 50% in calendar year 2026.

πŸ’΅ TXN trades at a forward P/E of 36.94, significantly lower than LRCX's 48.82 multiple.

πŸ“‰ LRCX shares gained 121.3% year-to-date compared to TXN's 74.4% increase in the same period.

πŸ† TXN holds a Zacks Rank #1 (Strong Buy) while LRCX carries a Zacks Rank #2 (Buy).

πŸ”‹ TXN supplies essential analog chips for power delivery, cooling, and connectivity in data centers.

Bullish Signals
  • TXN delivered strong Q1 2026 results with 19% revenue growth and 31% EPS growth, demonstrating robust execution.
  • The company's data center segment is a major growth engine, with Q1 2026 revenues surging 90% year-over-year.
  • TXN's manufacturing strategy is yielding results, expanding non-GAAP gross margins by 120 basis points to 58%.
  • Lam Research raised its full-year 2026 equipment spending outlook to $140 billion, indicating strong customer demand.
  • LRCX beat earnings estimates in Q3 fiscal 2026 with EPS surpassing consensus by 8.1%.
  • Advanced packaging revenues for LRCX are projected to grow over 50% in calendar 2026 due to AI chip demand.
  • TXN offers a more attractive valuation with a forward P/E of 36.94 compared to LRCX's 48.82.
  • Both companies benefit from the broader AI-driven technology cycle and recovery in semiconductor demand.
Risk Factors
  • Lam Research trades at a premium valuation with a forward P/E of 48.82, which may limit upside if growth slows.
  • TXN's Q2 2026 revenue guidance ($5.00-$5.40 billion) is slightly below the Zacks Consensus Estimate of $5.22 billion.
  • LRCX's stock has already rallied significantly with a 121.3% year-to-date gain, potentially pricing in much of the AI optimism.
Full Analysis
Texas Instruments (TXN) and Lam Research (LRCX) are compared as semiconductor investment options, with TXN focusing on analog/embedded chips for industrial, automotive, and data center sectors, while LRCX provides wafer fabrication equipment. Both companies are benefiting from the AI-driven technology cycle and recovering demand, but investors must weigh growth prospects against valuation and risk profiles. Texas Instruments reported a strong start to 2026 with first-quarter revenues up 19% year-over-year to $4.83 billion and EPS rising 31% to $1.68. The data center segment is a key growth driver, reaching an annual run rate of approximately $1.2 billion in 2025 and surging 90% year-over-year in Q1 2026. TXN's manufacturing advantage, including expanding 300mm wafer capacity, contributed to non-GAAP gross margins expanding 120 basis points to 58%. Lam Research capitalized on AI spending with fiscal 2026 WFE spending outlook raised to $140 billion. In Q3 fiscal 2026, revenues rose 23.8% to $5.84 billion and non-GAAP EPS increased 41.3% to $1.47. LRCX expects advanced packaging revenues to grow over 50% in calendar 2026, with non-GAAP operating margins expanding to 36.5% in Q4 fiscal 2026. Valuation analysis favors Texas Instruments, which trades at a forward P/E of 36.94 compared to LRCX's 48.82. While LRCX shares have gained 121.3% year-to-date versus TXN's 74.4%, the article concludes that TXN offers a better risk-reward mix due to its lower valuation, diversified end markets, and stable growth trajectory, earning it a Zacks Rank #1 compared to LRCX's Rank #2.